Galapagos NV (GLPG) Company Profile
Galapagos NV is a Belgium-based biotechnology company. The Company’s activities are divided into two operating divisions: Research and Development (R & D) and Services. The R & D division is engaged in the discovery and development of small molecules. The Services division, offers target-to-drug discovery products and services to pharmaceutical and biotechnology companies and to patient foundations, encompassing target discovery and validation, screening and drug discovery through to delivery of pre-clinical candidates. As of December 31, 2011, Galapagos NV was, through its subsidiaries, active in Belgium, France, Switzerland, the Netherlands, the United Kingdom, Germany, the United States and Croatia. In April 2014, it sold BioFocus and Argenta service division operations to Charles River Laboratories International.
News about GLPG
3 Top Healthcare Stocks to Buy in April
There have been more stock market pops and drops lately and that might have you wondering what healthcare stocks can be bought to take advantage of this volatility. Buying healthcare stocks during periods of volatility can be smart because demand for...Read More>>>
Why These High-Flying Stocks Will Keep Delivering Big Gains
Our investing experts have made some tremendous picks over the last several years, outperforming the S&P 500 by 100%, 200%, or even as much as 700% in the case of Money Morning Executive Editor Bill Patalon's 2012 pick of Galapagos NV (N...Read More>>>
Seattle Genetics: A Buy After Brilliant Acquisition
Shares of Seattle Genetics (NASDAQ:SGEN) have risen by over 75% during the past three years as management continues to successfully execute. However, the stock has floundered in the past year, posting a loss of negative 6% or so. Figure 1: SGEN da...Read More>>>
What Can We Expect From Gilead?
Article thesis In about two weeks Gilead (GILD) will report its fourth-quarter results, and I believe that the company has a good chance of beating estimates once again. With tailwinds such as the Yescarta roll-out and the approval of Sovaldi in Chin...Read More>>>
Orbimed Advisors Llc Buys Clementia Pharmaceuticals Inc, Aetna Inc, Universal Health Services Inc, S
New York, NY, based Investment company Orbimed Advisors Llc buys Clementia Pharmaceuticals Inc, Aetna Inc, Universal Health Services Inc, Immunomedics Inc, Kala Pharmaceuticals Inc, Alnylam Pharmaceuticals Inc, Juno Therapeutics Inc, Regeneron Pharma...Read More>>>